Dan Brennan
Stock Analyst at TD Cowen
(4.03)
# 579
Out of 4,667 analysts
101
Total ratings
49.37%
Success rate
12.66%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Buy | $155 → $175 | $167.88 | +4.24% | 4 | Nov 13, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $240 → $250 | $187.90 | +33.05% | 5 | Nov 7, 2024 | |
| BRKR Bruker | Maintains: Hold | $72 → $70 | $53.37 | +31.16% | 1 | Nov 6, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $90 → $82 | $52.70 | +55.60% | 5 | Nov 6, 2024 | |
| ILMN Illumina | Maintains: Buy | $166 → $177 | $131.68 | +34.42% | 12 | Nov 5, 2024 | |
| RVTY Revvity | Maintains: Buy | $141 → $144 | $111.34 | +29.33% | 3 | Nov 5, 2024 | |
| WAT Waters | Maintains: Hold | $363 → $410 | $357.77 | +14.60% | 3 | Nov 4, 2024 | |
| DHR Danaher | Maintains: Buy | $310 → $315 | $233.10 | +35.14% | 5 | Oct 23, 2024 | |
| A Agilent Technologies | Maintains: Buy | $153 → $160 | $128.57 | +24.45% | 12 | Aug 22, 2024 | |
| GH Guardant Health | Maintains: Buy | $41 → $42 | $30.68 | +36.90% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8.5 → $11 | $4.82 | +128.22% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $15.30 | +96.08% | 1 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $50 | $69.38 | -27.93% | 2 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $20.14 | +53.92% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $648 → $658 | $512.84 | +28.31% | 12 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $42.22 | +20.80% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $58.15 | -14.02% | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2.8 | $1.19 | +135.29% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $20 | $15.36 | +30.21% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $13.32 | +140.24% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $308.31 | +77.09% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.62 | +332.10% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.72 | +772.09% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $203.67 | +13.91% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,166.90 | -24.59% | 3 | Oct 7, 2020 |
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $167.88
Upside: +4.24%
Charles River Laboratories International
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $187.90
Upside: +33.05%
Bruker
Nov 6, 2024
Maintains: Hold
Price Target: $72 → $70
Current: $53.37
Upside: +31.16%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $90 → $82
Current: $52.70
Upside: +55.60%
Illumina
Nov 5, 2024
Maintains: Buy
Price Target: $166 → $177
Current: $131.68
Upside: +34.42%
Revvity
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $111.34
Upside: +29.33%
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $363 → $410
Current: $357.77
Upside: +14.60%
Danaher
Oct 23, 2024
Maintains: Buy
Price Target: $310 → $315
Current: $233.10
Upside: +35.14%
Agilent Technologies
Aug 22, 2024
Maintains: Buy
Price Target: $153 → $160
Current: $128.57
Upside: +24.45%
Guardant Health
Aug 8, 2024
Maintains: Buy
Price Target: $41 → $42
Current: $30.68
Upside: +36.90%
Aug 8, 2024
Maintains: Neutral
Price Target: $8.5 → $11
Current: $4.82
Upside: +128.22%
Aug 7, 2024
Maintains: Hold
Price Target: $28 → $30
Current: $15.30
Upside: +96.08%
Jul 31, 2024
Maintains: Buy
Price Target: $46 → $50
Current: $69.38
Upside: -27.93%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $20.14
Upside: +53.92%
Jul 25, 2024
Maintains: Buy
Price Target: $648 → $658
Current: $512.84
Upside: +28.31%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $42.22
Upside: +20.80%
Jul 9, 2024
Initiates: Buy
Price Target: $50
Current: $58.15
Upside: -14.02%
May 13, 2024
Initiates: Buy
Price Target: $2.8
Current: $1.19
Upside: +135.29%
May 1, 2024
Maintains: Buy
Price Target: $21 → $20
Current: $15.36
Upside: +30.21%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $13.32
Upside: +140.24%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $308.31
Upside: +77.09%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $1.62
Upside: +332.10%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.72
Upside: +772.09%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $203.67
Upside: +13.91%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,166.90
Upside: -24.59%